NO20090233L - Ny sammensetning som har affinitet for amyloid - Google Patents

Ny sammensetning som har affinitet for amyloid

Info

Publication number
NO20090233L
NO20090233L NO20090233A NO20090233A NO20090233L NO 20090233 L NO20090233 L NO 20090233L NO 20090233 A NO20090233 A NO 20090233A NO 20090233 A NO20090233 A NO 20090233A NO 20090233 L NO20090233 L NO 20090233L
Authority
NO
Norway
Prior art keywords
amyloid
affinity
salt
carbon atoms
substituent
Prior art date
Application number
NO20090233A
Other languages
English (en)
Inventor
Akio Hayashi
Anthony Eamon Storey
Denis Raymond Christophe Bouvet
Daisaku Nakamura
Shigeyuki Tanifuji
Shinya Takasaki
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20090233L publication Critical patent/NO20090233L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives en forbindelse som har affinitet mot amyloid, som viser tilstrekkelig hurtig klaring fra normal vev, og som har lav toksisitet som mutagenisitet, og som har den generelle formel (1): eller et salt derav, der R1 er en gruppe valgt fra hydrogen, hydroksyl, karboksyl, sulfat, amino, nitro, cyano, en alkylsubstituent med ett til 4 karbonatomer eller en alkoksysubstituent med ett til 4 karbonatomer; R2 er en radioaktiv halogensubstituent; og m er et helt tall 0 til 2, og et lav-toksisk diagnostisk middel for Alzheimers sykdom omfattende en forbindelse representert ved formelen ovenfor eller et salt derav.
NO20090233A 2006-06-21 2009-01-14 Ny sammensetning som har affinitet for amyloid NO20090233L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80535606P 2006-06-21 2006-06-21
JP2006188034 2006-07-07
PCT/JP2007/062503 WO2007148755A1 (ja) 2006-06-21 2007-06-21 新規アミロイド親和性化合物

Publications (1)

Publication Number Publication Date
NO20090233L true NO20090233L (no) 2009-02-11

Family

ID=38833493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090233A NO20090233L (no) 2006-06-21 2009-01-14 Ny sammensetning som har affinitet for amyloid

Country Status (10)

Country Link
US (1) US8277777B2 (no)
EP (1) EP2042501B1 (no)
KR (1) KR20090025282A (no)
CN (1) CN101501033B (no)
AU (1) AU2007261985B2 (no)
CA (1) CA2655826A1 (no)
HK (1) HK1133254A1 (no)
IL (1) IL196046A0 (no)
NO (1) NO20090233L (no)
WO (1) WO2007148755A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
AU2007252658B2 (en) * 2006-05-19 2012-03-29 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
TW200823211A (en) * 2006-11-30 2008-06-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
CA2703649A1 (en) * 2007-10-24 2009-04-30 Shigeyuki Tanifuji Novel compound having affinity for amyloid
EP2213671A4 (en) * 2007-10-26 2012-02-22 Nihon Mediphysics Co Ltd NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
IN2014DN00185A (no) 2011-06-24 2015-07-10 Nihon Mediphysics Co Ltd
RU2015147450A (ru) 2013-04-29 2017-06-05 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ 2-ФЕНИЛ ИЛИ 2-ГЕТЕРОАРИЛ ИМИДАЗОЛ[1,2-a]ПИРИДИНА
CN103724207B (zh) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 苯基苄基醚类衍生物及其制备方法和应用
EA039923B1 (ru) * 2014-08-29 2022-03-28 Сиэйчдиай Фаундэйшн, Инк. Зонды для визуализации белка хантингтина
US9926316B2 (en) * 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
CN108822105A (zh) * 2018-08-14 2018-11-16 河南师范大学 一种由乙苯类化合物合成2-芳基咪唑并[1,2-a]吡啶类化合物的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833149A (en) * 1986-09-22 1989-05-23 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
US4727145A (en) * 1986-09-22 1988-02-23 Ortho Pharmaceutical Corporation 2- Or 3- aryl substituted imidazo [1,2-a]pyridines
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
BR9611047A (pt) * 1995-10-17 2000-03-08 Searle & Co Processo de deteção de ciclo oxigenase-2
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
EP1105163A4 (en) 1998-08-20 2003-05-02 Univ California METHOD FOR MARKING AMYLOID PLAQUES AND NEUROFIBRILLIC GIFTS
JP4025468B2 (ja) 1999-07-29 2007-12-19 三井化学株式会社 有機電界発光素子
US6489337B1 (en) 2000-03-31 2002-12-03 Ortho-Mcneil Pharmaceutical, Inc. Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo[1,2-a] pyridines
US20010051632A1 (en) * 2000-03-31 2001-12-13 Wenying Chai Phenyl-substituted indolizines and tetrahydroindolizines
ATE361297T1 (de) * 2000-03-31 2007-05-15 Ortho Mcneil Pharm Inc Phenyl-substituierte imidazopyridine
DE10040016A1 (de) 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US6514969B2 (en) * 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
ES2536449T3 (es) 2000-08-24 2015-05-25 University Of Pittsburgh Of The Commonwealth System Of Higher Education Derivados de tioflavina para uso en diagnosis de la enfermedad de Alzheimer
JP2004529884A (ja) * 2001-02-26 2004-09-30 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー 金属放射性医薬のためのアスコルビン酸類似体
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
DE60217090T2 (de) * 2001-04-23 2007-07-12 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
DK1432453T3 (da) 2001-08-27 2013-11-18 Univ Pennsylvania Stilbenderivater og anvendelse heraf til binding og billeddannelse af amyloid-plaques
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds
EP1356827A1 (en) * 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
WO2003106439A1 (ja) 2002-06-12 2003-12-24 株式会社ビーエフ研究所 アミロイド蓄積性疾患の画像診断プローブ化合物、老人斑／びまん性老人斑染色用化合物、ならびにアミロイド蓄積性疾患の治療薬
EP2229957A3 (en) 2002-11-05 2010-10-06 Ion Beam Applications S.A. Stabilization of aqueous compositions of 18f-isotope labelled 2-fluoro-2-deoxy-d-glucose with ethanol
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
NZ548098A (en) 2003-12-31 2010-05-28 Schering Plough Ltd Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
AU2006261917A1 (en) * 2005-06-24 2007-01-04 The Trustees Of The University Of Pennsylvania Radiolabeled-pegylation of ligands for use as imaging agents
US20080219922A1 (en) * 2005-09-12 2008-09-11 Goodman Mark M Alzheimer's Disease Imaging Agents
AU2007252658B2 (en) * 2006-05-19 2012-03-29 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
CA2703649A1 (en) * 2007-10-24 2009-04-30 Shigeyuki Tanifuji Novel compound having affinity for amyloid
EP2213671A4 (en) * 2007-10-26 2012-02-22 Nihon Mediphysics Co Ltd NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID
CA2704139A1 (en) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. Utilization of novel compounds with amyloid affinity and method of producing the same

Also Published As

Publication number Publication date
CA2655826A1 (en) 2007-12-27
AU2007261985A1 (en) 2007-12-27
HK1133254A1 (en) 2010-03-19
EP2042501A1 (en) 2009-04-01
EP2042501B1 (en) 2017-04-12
AU2007261985B2 (en) 2012-04-19
WO2007148755A1 (ja) 2007-12-27
US20100092387A1 (en) 2010-04-15
CN101501033B (zh) 2012-08-01
EP2042501A4 (en) 2012-11-21
KR20090025282A (ko) 2009-03-10
US8277777B2 (en) 2012-10-02
CN101501033A (zh) 2009-08-05
IL196046A0 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
NO20090233L (no) Ny sammensetning som har affinitet for amyloid
NO20085265L (no) Nye forbindelser som har affinitet for amyloid
WO2009054497A1 (ja) 新規アミロイド親和性化合物
NO20084897L (no) Ny forbindelse med affinitet til amuloid
MX2008014898A (es) Composicion para el diagnostico de enfermedades relacionadas con amiloides.
EA201070323A1 (ru) Замещенное производное пиразола
UA105185C2 (uk) Піроли
NO20074718L (no) BCRP/ABCG2 inhibitor
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
MY153045A (en) Oxopyrazine derivative and herbicide
WO2009054496A1 (ja) 新規アミロイド親和性化合物
NO20065578L (no) Substituerte metylaryl eller heteroarylamidforbindelser
ATE515505T1 (de) Heterocyclische fxr-bindende verbindungen
IL198995A0 (en) Novel compound having affinity for amyloid
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
NO20076524L (no) Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme
MY142807A (en) Benzimidazole derivative and use thereof.
NO20073720L (no) Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
NO20082747L (no) Arylisoksazol-4-yl-imidazolderivater
MX2010001566A (es) Derivado de aminopirazolamida.
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
MY161992A (en) Novel tetrahydroisoquinoline derivative

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application